Roberta Camisa
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Monoclonal and Polyclonal Antibodies Research
Papers in
- Oncology 25
- HER2/EGFR in Cancer Research 10
- Colorectal Cancer Treatments and Studies 7
- Cancer Treatment and Pharmacology 4
-
- Lung Cancer Treatments and Mutations 10
- Co-authors
- Nadia Naldi (17 shared papers)Andrea Ardizzoni (14 shared papers)Marzia Capelletti (7 shared papers)Antonino Musolino (8 shared papers)Debora Pezzuolo (6 shared papers)Beatrice Bortesi (7 shared papers)Tauro Maria Neri (5 shared papers)Giancarlo Bisagni (5 shared papers)
In The Last Decade
Roberta Camisa
43 papers receiving 1.5k citations
Roberta Camisa's Hit Papers
Peers
Comparison fields: 5 of 87
- Oncology 872
- Radiology, Nuclear Medicine and Imaging 535
- Cancer Research 290
- Immunology 364
- Genetics 115
Countries citing papers authored by Roberta Camisa
This map shows the geographic impact of Roberta Camisa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Camisa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Camisa more than expected).
Fields of papers citing papers by Roberta Camisa
This network shows the impact of papers produced by Roberta Camisa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Camisa. The network helps show where Roberta Camisa may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberta Camisa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/ neu –Positive Metastatic Breast Cancer Hit paper breakdown → | 2008 | 745 |
| 2 | 2007 | 101 | |
| 3 | 2009 | 61 | |
| 4 | 2014 | 59 | |
| 5 | 2000 | 43 | |
| 6 | 2016 | 37 | |
| 7 | 2003 | 35 | |
| 8 | 2006 | 32 | |
| 9 | 1995 | 30 | |
| 10 | 2006 | 27 | |
| 11 | 2003 | 27 | |
| 12 | 1994 | 25 | |
| 13 | 2003 | 24 | |
| 14 | 2008 | 23 | |
| 15 | Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon alpha-2a as first-line endocrine treatments in advanced breast cancer: updated results of a phase II, prospective, randomised multicentre trial. | 2007 | 20 |
| 16 | 2009 | 18 | |
| 17 | 2007 | 17 | |
| 18 | 2012 | 16 | |
| 19 | 1997 | 15 | |
| 20 | 2005 | 14 |
About Roberta Camisa
Roberta Camisa is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Cancer Research and Molecular Biology, having authored 44 papers that have together received 1.5k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (12 papers), HER2/EGFR in Cancer Research (10 papers), Lung Cancer Treatments and Mutations (10 papers), Breast Lesions and Carcinomas (8 papers), Colorectal Cancer Treatments and Studies (7 papers), Cancer Genomics and Diagnostics (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Oncology (872 citations), Radiology, Nuclear Medicine and Imaging (535 citations), Cancer Research (290 citations), Immunology (364 citations) and Genetics (115 citations). Roberta Camisa has collaborated with scholars based in Italy, Belgium and Canada. Frequent co-authors include Nadia Naldi, Andrea Ardizzoni, Marzia Capelletti, Antonino Musolino, Debora Pezzuolo, Beatrice Bortesi, Tauro Maria Neri, Giancarlo Bisagni, Gabriele Missale and Diletta Laccabue. Their work appears in journals such as Cancer, Lung Cancer, Diagnostic Cytopathology, Journal of Clinical Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.